Antithrombotic therapy resumption after intracranial hemorrhage
10.3760/cma.j.cn113694-20220617-00488
- VernacularTitle:颅内出血后重启抗血栓治疗的研究进展
- Author:
Shengde LI
1
;
Jun NI
;
Bin PENG
Author Information
1. 中国医学科学院北京协和医学院北京协和医院神经科，北京 100730
- Keywords:
Intracranial hemorrhage;
Anticoagulants;
Platelet aggregation inhibitors;
Thromboembolism;
Recurrence
- From:
Chinese Journal of Neurology
2023;56(2):204-211
- CountryChina
- Language:Chinese
-
Abstract:
Patients with intracranial hemorrhage and indications of antithrombotic therapy are common in clinical practice. However, whether and when to start anticoagulant or antiplatelet therapy after intracranial hemorrhage are still debatable. Clinicians are posed with huge challenges without available guidelines. Through reviewing relevant literature, this article analyzed the risks of thromboembolism and hemorrhage recurrence after initiation of anticoagulant or antiplatelet therapy in patients with intracranial hemorrhage due to various etiologies. This article also presented the initiation time and specific antithrombotic plan in current clinical practice, aiming to propose references for clinicians.
